1 |
Orgeas, C. C., K. Sanner, P. Hall, P. Conner, J. Holte, S. J. Nilson, K. Sundfeldt, I. Persson, K. S. Chia, S. Wedron, P. W. Dickman and K. Czene. 2009. Breast cancer incident after hormonal treatment of infertility in Sweden: a cohort study. Am. J. Obstel. Gynecol. 200(1):72-77.
|
2 |
Plourde, P. V., H. E. Kulin and S. J. Santner. 1983. Clomiphene in treatment of adolescent gynacomastia: Clinical and endocrine studies. Am. J. Dis. Child. 137(11):1080-1082.
DOI
|
3 |
Randal, J. M. and A. Templeton. 1991. The effects of clomiphene citrate upon ovulation and endocrinology when administered to patients with unexplained infertility. Hum. Reprod. 6(5):659-664.
|
4 |
Schardein, J. L. 1980. Congenital abnormalities and harmones during pregnancy: A clinical review. Clin. Teratol. 22(3):251-270.
DOI
ScienceOn
|
5 |
ESHRE Capri Workshop Group, 1995. Anovulatory infertility. Hum. Reprod. 10:1549-1553.
DOI
ScienceOn
|
6 |
Haring, D. A. J. P., M. C. Cornel, J. C. Van der Linden, J. M. G. Van Vugt and M. L. Kwee. 2005. Acardius acephalus after induced ovulation: a case report. Clin. Teratol. 47(4):257-262.
|
7 |
Harmon, J. R., W. S. Branham and D. M. Sheehan. 2005. Transplacental estrogen responses in the fetal rat: Increased uterine weight and ornithine decarboxylase activity. Dev. Pharmacol. Toxicol. 39(3):253-260.
|
8 |
Kennedy, J. L. and E. Y. Adashi. 1987. Ovulation induction. Obstet. Gynecol. Clin. North Am. 14(4):831-864.
|
9 |
Lerner- Geva, L., L. Keinan-Boker, T. Blumstein, V. Boyko, L. Olmar, S. Mashiac, J. Rabinovici, G. Potashnick, E. Lunenfeld, J. G. Schenker, A. Shushan, A. Fishman, I. Cohen, I. Vagman and B. Lunenfeld. 2006. Infertility, ovulation induction treatments and the incidence of breast cancer-A historical prospective cohort of Israeli Women. Breast Cancer Res. Treat. 100(2):201-212.
DOI
|
10 |
Macklon, N. S., R. L. Stoufer, L. C. Giudice and B. C. J. M. Fauser. 2006. The science behind 25 years of ovarian stimulationfor in vitro fertilization. Endocr. Rev. 27(2):170-207.
DOI
ScienceOn
|
11 |
Martikainen, H., L. Ronnberg, A. Roukonen and A. Kauppila. 2006. Effect of clomiphene citrate on prolactin and gonadotropin release during GnRH- analog treatment. Theriogenology 66(6-7):1560-1567.
DOI
ScienceOn
|
12 |
Mckenna, M. and R. J. Pepperell. 1988. Anti-oestrogens. Obstel. Gynaecol. 2:545-561.
|
13 |
Morris, J. M. 1970. Postcoital antifertility agents and their teratogenic effects. Contraception 2:85-97.
DOI
ScienceOn
|
14 |
Motta, C. M. and J. S. Hutchinson. 1991. Effects of clomiphene citrate on early pregnancy in guinea pigs. J. Reprod. Fertil. 92: 65-73.
DOI
ScienceOn
|
15 |
Bernstein, H. N. 1970. Some tatrogenic ocular diseases from systemically administered drugs. Int. Ophthalmol. Clin. 10: 553-618.
|
16 |
Csemiczky, G., J. Harlin and G. Fried. 2002. Predictive power of clomiphene citrate challenge test for failure of in vitro fertilization treatment. Acta. Obstet. Gynecol. Scand. 81(10): 954-961.
DOI
ScienceOn
|
17 |
Brackett, N. L., M. Abae, O. D. Padron and C. M. Lynne. 1995. Treatment by assisted conception of severe male factor infertility due to spinal cord injury or other neurologic impairment. J. Assist. Reprod. Genet. 12(3):210-216.
DOI
|
18 |
Casper, R. E. 2007. Aromatase inhibitors in ovarian stimulation. Steriod. Biochem. Mol. Biol. 106(1-5):71-75.
DOI
ScienceOn
|
19 |
Clark, J. H. and B. M. Markaverich. 1982. The agonistic-antagonistic properties of clomiphene: a review. Pharmacol. Therapeut. 15:467-519.
|
20 |
CSGN. 2006. http:/www.csgnetwork.com/glossary.html#calculator
|
21 |
Deveci, E., H. S. Inaloz, S. S. Inaloz and B. Unal. 2000. Effect of clomiphene citrate on neonatal rat skin. Clin. Exp. Obstel. Gynecol. 27(3-4):238-240.
|
22 |
Dickey, R. P. and D. E. Holtkamp. 1996. Development, pharmacology and clinical experience with clomiphene citrate. Hum. Reprod. Update. 2(6):483-506.
DOI
|
23 |
Duncan, D. B. 1955. Multiple range and multiple F tests. Biometrics 11:1-42.
DOI
ScienceOn
|
24 |
Dziadek, M. 2005. Preovulatory administration of clomiphene citrate to mice causes fetal growth retardation and neural tube defects (exencephaly) by an indirects maternal effect. Exp. Teratol. 47(4):263-273.
|
25 |
Elizur, S. E. and T. Tulandi. 2008. Drugs in fertility and fetal safety. Fertil. Steril. 89(6):1595-1602.
DOI
ScienceOn
|
26 |
Arriaga-Alba, M., R. Flores-Paz, R. Diaz-Hernandez and M. E. Gonzalez-Patino. 2001. Assesssment of genetic toxicity of the exposure of clomiphene citrate, with various bacterial test systems. Teratog. Carcing. Mutagen. 21(3):213-221.
DOI
ScienceOn
|
27 |
Adashi, E. Y. 1993. Clomiphene citrate: the case of monoisomeric preparations. Baillieres. Clin. Obstet. Gynaecol. 7:331-347.
DOI
ScienceOn
|
28 |
Aker, H. and O. M. Bulay. 1985. Three Neon et al Ca Taract Cases produced in rats with clomiphene citrate. J. Med. Bes. 3(2): 185-188.
|
29 |
Alatas, C., E. Aksoy, B. Cenglz and M. Bahceci. 1995. Clomiphene citrate and phocomelia. Arch. Genaecol. Obstet. 256(1):33-34.
DOI
|
30 |
Asch, R. H. and R. B. Greenblatt. 1976. Update on the safety and efficacy of clomiphene citrate as a therapeutic agent. J. Reprod. Med. 17(3):175-180.
|
31 |
Banhidy, F., N. Acs and A. E. Czeizel. 2008. Ovarian cysts, clomiphene therapy and the risk of neural tube defects. Int. J. Obstet. Genecol. 100(1):86-88.
DOI
ScienceOn
|